NCT05309187: Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors |
|
|
| Completed | 1 | 22 | US | IO-202, IO-202 + pembrolizumab combination therapy, IO-202 + Keytruda combination therapy, RP2D of IO-202 + pembrolizumab combination therapy in multiple solid tumor types, RP2D of IO-202 + Keytruda combination therapy | Immune-Onc Therapeutics | Solid Tumor, Adult | 03/24 | 05/24 | | |
NCT03594448: Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients |
|
|
| Terminated | N/A | 6 | US | Specimen Collection, Serial Liquid Biopsy | University of Southern California, National Cancer Institute (NCI) | Microsatellite Instability, Colorectal Cancer Stage IV | 09/23 | 09/23 | | |
